Cite
HARVARD Citation
Toama, W. et al. (2020). Ruxolitinib for steroid‐refractory acute graft‐versus‐host disease. Transplant international. pp. 244-246. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toama, W. et al. (2020). Ruxolitinib for steroid‐refractory acute graft‐versus‐host disease. Transplant international. pp. 244-246. [Online].